lenalidomide,iberdomide,dexamethasone,daratumumab,bortezomib,carfilzomib
janssen,takeda,amgen,bms
designer derivatives of the revlimid offer increased efficacy and the option of targeting different effects on the immune system to subsets of patients. #ims2022 #imw22 
Clinician and researcher; committed to improving outcomes of myeloma, amyloid and Waldenstrom's.